Zymeworks (ZYME) Intangibles (2021 - 2026)
Zymeworks' (ZYME) quarterly Intangibles came in at $1.2 million in Q1 2026, down 65.08% year-on-year from $3.4 million in Q1 2025, and down 13.04% quarter-over-quarter from $1.3 million in Q4 2025.
Zymeworks (ZYME) Intangibles (2021 - 2026) Analysis & Trends
Zymeworks has disclosed Intangibles across 6 years of filings, most recently posting $1.2 million for Q1 2026.
- Intangibles for Q1 2026 came in at $1.2 million, down 65.08% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.2 million (down 65.08% YoY), and the FY2025 annual result was $1.3 million, down 70.5% from the prior year.
- Intangibles came in at $1.2 million for Q1 2026 at Zymeworks, down from $1.3 million in the prior quarter.
- In the past five years, Intangibles ranged from a high of $17.6 million in Q4 2022 to a low of $341000.0 in Q2 2024.
- The 5-year median for Intangibles is $6.4 million (2024), against an average of $7.8 million.
- Across the five-year window, Intangibles plunged 98.07% in 2024 and surged 499.71% in 2025, its largest moves.
- Zymeworks' Intangibles stood at $17.6 million in 2022, then changed by 0.0% to $17.6 million in 2023, then slumped by 74.04% to $4.6 million in 2024, then plunged by 70.5% to $1.3 million in 2025, then slipped by 13.04% to $1.2 million in 2026.
- The last three Intangibles figures came in at $1.2 million (Q1 2026), $1.3 million (Q4 2025), and $1.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 4.41 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 30.30 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 418.50 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 7.73 Mn |
| 10 | Zymeworks | 1.73 Bn | 1.36 Bn | - | 1.17 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.17 Mn |
| Dec 31, 2025 | 1.35 Mn |
| Sep 30, 2025 | 1.40 Mn |
| Jun 30, 2025 | 2.05 Mn |
| Mar 31, 2025 | 3.36 Mn |
| Dec 31, 2024 | 4.58 Mn |
| Sep 30, 2024 | 6.41 Mn |
| Jun 30, 2024 | 341,000.00 |
| Mar 31, 2024 | 17.63 Mn |
| Dec 31, 2023 | 17.63 Mn |
| Sep 30, 2023 | 8.00 Mn |
| Jun 30, 2023 | 17.63 Mn |
| Mar 31, 2023 | 8.08 Mn |
| Dec 31, 2022 | 17.63 Mn |
| Sep 30, 2022 | 9.02 Mn |
| Dec 31, 2021 | 17.63 Mn |